Mannose-specific plant and microbial lectins as antiviral agents: A review
- PMID: 38244136
- DOI: 10.1007/s10719-023-10142-7
Mannose-specific plant and microbial lectins as antiviral agents: A review
Abstract
Lectins are non-immunological carbohydrate-binding proteins classified on the basis of their structure, origin, and sugar specificity. The binding specificity of such proteins with the surface glycan moiety determines their activity and clinical applications. Thus, lectins hold great potential as diagnostic and drug discovery agents and as novel biopharmaceutical products. In recent years, significant advancements have been made in understanding plant and microbial lectins as therapeutic agents against various viral diseases. Among them, mannose-specific lectins have being proven as promising antiviral agents against a variety of viruses, such as HIV, Influenza, Herpes, Ebola, Hepatitis, Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) and most recent Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The binding of mannose-binding lectins (MBLs) from plants and microbes to high-mannose containing N-glycans (which may be simple or complex) of glycoproteins found on the surface of viruses has been found to be highly specific and mainly responsible for their antiviral activity. MBLs target various steps in the viral life cycle, including viral attachment, entry and replication. The present review discusses the brief classification and structure of lectins along with antiviral activity of various mannose-specific lectins from plants and microbial sources and their diagnostic and therapeutic applications against viral diseases.
Keywords: Antiviral agents; Mannose-specific lectins; Plant lectins; Viruses.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses.Cells. 2022 Jan 20;11(3):339. doi: 10.3390/cells11030339. Cells. 2022. PMID: 35159151 Free PMC article. Review.
-
Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.Biomed Pharmacother. 2022 Feb;146:112507. doi: 10.1016/j.biopha.2021.112507. Epub 2021 Dec 7. Biomed Pharmacother. 2022. PMID: 34891122 Free PMC article. Review.
-
Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.Mar Drugs. 2020 Oct 29;18(11):543. doi: 10.3390/md18110543. Mar Drugs. 2020. PMID: 33138151 Free PMC article. Review.
-
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619. Cells. 2021. PMID: 34203435 Free PMC article. Review.
-
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.Mol Cell Biochem. 2021 Aug;476(8):2917-2942. doi: 10.1007/s11010-021-04107-3. Epub 2021 Mar 21. Mol Cell Biochem. 2021. PMID: 33745077 Free PMC article. Review.
Cited by
-
Identification of a Novel Antiviral Lectin against SARS-CoV-2 Omicron Variant from Shiitake-Mushroom-Derived Vesicle-like Nanoparticles.Viruses. 2024 Sep 30;16(10):1546. doi: 10.3390/v16101546. Viruses. 2024. PMID: 39459880 Free PMC article.
-
Water-glycan interactions drive the SARS-CoV-2 spike dynamics: insights into glycan-gate control and camouflage mechanisms.Chem Sci. 2024 Aug 23;15(35):14177-87. doi: 10.1039/d4sc04364b. Online ahead of print. Chem Sci. 2024. PMID: 39220162 Free PMC article.
References
-
- Friedrich, M.J.: WHO’s top health threats for 2019. JAMA 321(11), 1041 (2019) - PubMed
-
- Kausar, S., Said Khan, F., Ishaq Mujeeb Ur Rehman, M., Akram, M., Riaz, M., Rasool, G., Hamid Khan, A., Saleem, I., Shamim, S., Malik, A.: A review: Mechanism of action of antiviral drugs. Int. J. Immunopathol. Pharmacol. 35, 20587384211002621 (2021)
-
- Elfakharany, E., Gerges, M., Behery, E., Mohsen, A., Belald, F.: COVID-19 coronavirus: Pathogenesis, clinical features, diagnostics, epidemiology, prevention and control. Appl. Pharm. 12, 65–66 (2020)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous